The anti-cancer activity of Dioscin: an update and future perspective
Medical Oncology · 03.02.2025 · 42 (3)
DOI: 10.1007/s12032-024-02572-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Oncology, online erschienen am 03.02.2025. Verfasst von MengYue Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China. Hauptthemen laut MEDLINE: Diosgenin, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Natural drugs have the advantages of multi-pathway, multi-target, low toxicity, and high efficiency, which make them widely used and effective in anti-tumor therapy. Dioscin is a steroidal saponin compound that can be extracted from Dioscaceae plants. In recent years, it has been found that Dioscin has potent anti-tumor effects, can inhibit tumor cell proliferation, induce apoptosis and autophagy, inhibits tumor cell metastasis, reverses multidrug resistance, and increases sensitivity to anticancer drugs, and thus inhibit tumor progression. Meanwhile, the construction of Dioscin nanocarriers can improve the efficiency of drug use, reduce drug toxicity, realize the precise delivery of drugs, and improve the bioavailability of Dioscin. In this paper, the anticancer mechanism and targets of Dioscin in recent years were reviewed, thereby providing new ideas and a theoretical basis for further research and promotion of Dioscin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China.
- Shandong Co-Innovation Center of Classic TCM Formula, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China.
- Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China.
- Shandong Co-Innovation Center of Classic TCM Formula, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China. chenqian@sdutcm.edu.cn.
- Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China. chenqian@sdutcm.edu.cn.
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China. pathology@163.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, M., Zhang, Y., Ni, S., Sun, M., Wu, Q., Wu, X., Chen, Q., & Wang, S. (2025). The anti-cancer activity of Dioscin: an update and future perspective. Medical Oncology, 42(3). https://doi.org/10.1007/s12032-024-02572-6
Vancouver
Wang M, Zhang Y, Ni S, Sun M, Wu Q, Wu X, et al. The anti-cancer activity of Dioscin: an update and future perspective. Medical Oncology. 2025;42(3). doi:10.1007/s12032-024-02572-6
BibTeX
@article{Wang2025,
author = {Wang, MengYue and Zhang, YaNan and Ni, SongLin and Sun, Mo and Wu, QiaoLan and Wu, XiaoLin and Chen, Qian and Wang, ShiJun},
title = {The anti-cancer activity of Dioscin: an update and future perspective},
journal = {Medical Oncology},
year = {2025},
volume = {42},
number = {3},
doi = {10.1007/s12032-024-02572-6}
}
EUVIMED